Articles From: Sanofi and MannKind Announce Global Licensing Agreement for Afrezza® (insulin human) Rapid-Acting Inhaled Insulin to Santander slides; Kingfisher climbs: Europe's big stock moves


2014/9/17
- Up to $200 Million Collaboration to Support Pioneering Science and New Treatments - PARIS and SOUTH SAN FRANCISCO, Calif.
Sign-up for Sanofi and MyoKardia Announce Groundbreaking Collaboration to Develop Targeted Therapies for Patients with Genetic Heart Disease investment picks
PARIS and TARRYTOWN, N.Y., July 9, 2014 (GLOBE NEWSWIRE) -- Sanofi (EURONEXT : SAN and NYSE : SNY) and Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) today announced positive results from a Phase 2b dose-ranging study of dupilumab, an investigational therapy, in adult patients with moderate-to-severe atopic dermatitis (AD), a serious, chronic form of eczema.
Sign-up for Sanofi and Regeneron Announce Positive Results from Phase 2b Study of Dupilumab in Patients with Moderate-to-Severe Atopic Dermatitis investment picks
- Alirocumab, an investigational treatment for hypercholesterolemia, showed a 62 percent reduction in LDL-C compared to placebo at 24 weeks on top of maximally-tolerated lipid-lowering therapy in ODYSSEY LONG TERM trial - PARIS and TARRYTOWN, N.Y. , Aug.
Sign-up for Sanofi and Regeneron Announce Presentation of Detailed Positive Results from Four Pivotal Alirocumab Trials at ESC Congress 2014 investment picks
- Primary efficacy endpoints met in all nine new trials of investigational PCSK9 inhibitor - PARIS and TARRYTOWN, N.Y. , July 30, 2014 /PRNewswire/ -- Sanofi (EURONEXT: SAN and NYSE: SNY) and Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) today announced that nine new Phase 3 ODYSSEY trials of alirocumab in people with hypercholesterolemia met their primary efficacy endpoint of a greater percent reduction from baseline in low-density lipoprotein cholesterol (LDL-C) at 24 weeks compared to placebo or active comparator.
Sign-up for Sanofi and Regeneron Report Positive Top-Line Results from Nine Phase 3 Trials of Alirocumab in People with Hypercholesterolemia investment picks
Sanofi Announces $2.5 Million Contribution to Dementia Research Canada NewsWire MONTREAL , Sept.
Sign-up for Sanofi Announces $2.5 Million Contribution to Dementia Research investment picks
2014/7/31
PARIS , July 31, 2014 /PRNewswire/ -- Sanofi, a global and diversified healthcare leader, reports results for the first half of 2014.
Sign-up for Sanofi H1 2014 Results - Interview with Chris Viehbacher investment picks
2014/8/12
Generics Division of Sanofi, Winthrop US, to Market the Drug BRIDGEWATER, N.J. , Aug.
Sign-up for Sanofi Launches Authorized Generic Version of Eloxatin® (oxaliplatin injection) investment picks
SEATTLE and SOUTH SAN FRANCISCO, Calif., Oct.
Sign-up for Sanofi Pasteur and Immune Design Enter Broad Collaboration for the Development of a Herpes Simplex Virus Therapy investment picks
2014/8/13
- Study Demonstrates Fluzone High-Dose Vaccine 24.2 Percent More Effective Than Standard-Dose Fluzone Vaccine in Preventing Influenza in Adults 65 Years of Age and Older - LYON, France , Aug.
Sign-up for Sanofi Pasteur Announces Publication of Positive Data for Fluzone® High-Dose Vaccine in The New England Journal of Medicine investment picks
2014/10/1
Sanofi Pasteur Introduces 4-Strain Influenza Vaccine in Canada Canada NewsWire TORONTO , Oct.
Sign-up for Sanofi Pasteur Introduces 4-Strain Influenza Vaccine in Canada investment picks
NEW YORK (MarketWatch) -- Sanofi (SNY)(fr:san) and MannKind Corp.
Sign-up for Sanofi, MannKind to commercialize Afrezza insulin therapy investment picks
PARIS , July 31, 2014 /PRNewswire/ -- Sanofi (NYSE: SNY; EURONEXT: SAN) Q2 2014 Change (reported) Change (CER) Net sales €8,075m +0.9% +6.4% Business net income (1) €1,537m +3.9% +13.0% Business EPS (2) €1.17 +4.5% +13.4% In order to facilitate an understanding of our operational performance, Sanofi comments on the business net income statement.
Sign-up for Sanofi: Solid Sales and Business EPS Growth at CER investment picks
School Slashes VM Backup and Restore Times by 90% with vmPRO and DXi SAN JOSE, Calif.
Sign-up for Santa Barbara City College Turns To Quantum To Meet VM Protection Challenge investment picks
VANCOUVER, Canada , July 28, 2014 /PRNewswire/ -- Santa Fe Gold Corporation (" Santa Fe ") (OTCQB: SFEG) is pleased to announce an updated resource estimate for the Summit Mine, located in New Mexico, USA .
Sign-up for Santa Fe Gold Announces Updated Resource Estimate for the Summit Mine investment picks
GREENVILLE, S.C., Aug.
Sign-up for Santa Fe Imaging Deploys eRAD RIS investment picks
2014/8/28
Parents Invited to Share Child's Outstanding Academic Accomplishments for Chance to Win Spot in Santander/Revolution "Soccer Scholars" Clinic BOSTON , Aug.
Sign-up for Santander And New England Revolution Encourage Parents To Share Their Child's Academic Achievements For Chance To Play With The Pros investment picks
2014/7/31
Return on average equity of 33.0 percent, and return on average assets of 3.4 percent.
Sign-up for Santander Consumer USA Holdings Inc. reports second quarter 2014 net income of $246 million, or $0.69 per diluted common share, up 35 percent from prior year. investment picks
The Federal Reserve announced Thursday that Santander Holdings USA Inc., the U.S. affiliate of Banco Santander (SAN) , has agreed to strengthen its management practices after the bank declared a cash dividend on its common stock that was not authorized in advance by the U.S. central bank.
Sign-up for Santander in pact with Fed after unauthorized dividend payment investment picks
2014/8/18
Trivia Contest Challenges Fans Knowledge of Eagles Alumni for the Chance to Kick a Field Goal and Win $20,000 during an Eagles Game BOSTON , Aug.
Sign-up for Santander Kicks Off "$20,000 Field Goal Challenge" For Philadelphia Eagles Fans investment picks
2014/9/11
BOSTON , Sept.
Sign-up for Santander Renews And Expands Its Commitment To Boston University investment picks
Shares of Banco Santander SA (ES:SAN) (SAN) fell 2% on Wednesday after the banking giant announced the death of Chairman Emilio Botin.
Sign-up for Santander shares down nearly 2% after chairman dies investment picks
By Sara Sjolin, MarketWatch LONDON (MarketWatch) -- Here are some of the companies whose shares are making notable moves in European trade on Wednesday.
Sign-up for Santander slides; Kingfisher climbs: Europe's big stock moves investment picks
Premium Membership: Features and Benefits
Wide-Moat Screener for Stocks

Put a moat around your portfolio. Sniff out the most promising opportunities that can ride through any market.

Gold Medalist Screener for Funds

Narrow the available universe of 5000 funds to the top rated gold and silver. Then, sort for manager tenure, expense ratio, risk and return to create your own index-beating fund watchlist.

Thousands of Premium Analyst Reports

While many of our competitors measure a stock's worth with a computer program, Morningstar's staff of 150+ analyst sift through company fillings, financial data and a wealth of other sources to deliver an unvarnished review of any investment. In fact, twelve Morningstar analysts have been recognized by WSJ as "Best on the Street" in the US.

Premium Portfolio Monitor

Make decisions with confidence. Load your investments into our research center and automatically connect to all our proprietary tools and data points.

Mobile

Never be without critical research. Free with your active membership, take our Premium data and guidance wherever you go with Morningstar for iPad®, iPhone®, and Android apps.

Morningstar's Guarantee

We're looking out for you. If after your 14-day free trial, you find that a Morningstar Premium membership is not for you, cancel any time and we'll be happy to refund the unused portion - no questions asked.

Go Premium!
Exclusive Premium Member Benefits
Get the best thinking of 150+ disciplined
objective, experienced analysts-dedicated to
specific industries and securities.
+2,500 Analyst Reports
Wide Moat Screener for Stocks
Medalist Screener for Funds
Premium Portfolio Manager with X-Ray & Monitor
Premium eNewsletters
Morningstar Basic Benefits (All)
Sign up now - No charge for the first 14 days
Articles From: Sanofi and MannKind Announce Global Licensing Agreement for Afrezza® (insulin human) Rapid-Acting Inhaled Insulin to Santander slides; Kingfisher climbs: Europe's big stock moves
Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol |  Title Star Rating |  Category |  Total Assets |  Top Holdings |  Top Sectors |  Symbol |  Name Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol / Ticker |  Title Star Rating |  Category |  Total Assets |  Symbol / Ticker |  Name Title |  Date |  Author |  Collection |  Popularity |  Interest Title |  Date |  Company |  Symbol |  Interest |  Popularity Title |  Date |  Company |  Symbol |  Interest |  Popularity Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Popularity |  Our Choices